Sustained release formulations of nalbuphine
AssigneeEndo Pharmaceuticals Inc.
InventorsAnand R. Baichwal, Philip A. Goliber, Anthony E. Carpanzano, Thomas Sciascia, Donald Diehl, II, Brian Vogler
Life of this patent
Estimating the term…
Abstract
Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
Claims24
An oral sustained release formulation of nalbuphine comprising nalbuphine compound or a pharmaceutically acceptable salt thereof homogeneously dispersed within a hydrophilic gel matrix, wherein the hydrophilic gel matrix comprises xanthan gum, a hydrophilic cellulose ether or both, wherein the formulation provides an analgesic effect for at least about 8 hours.
Dependencies are inferred from the claim text.